JavaScript is off. Please enable to view full site.

U.S. FDA says India-made eye drop linked to some infections, blindness and one death

U.S. FDA says India-made eye drop linked to some infections, blindness and one death

Saturday, February 04, 2023, 11:25 GMT+7
U.S. FDA says India-made eye drop linked to some infections, blindness and one death
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. Photo: Reuters

NEW DELHI -- The U.S. Food and Drug Administration (FDA) has warned against using an eye drop made in India that has been linked to the outbreak of a drug-resistant bacteria leading to adverse events in at least 55 patients in the United States including infections, blindness and one death.

The agency said on Thursday that Artificial Tears eye drop manufactured by India's Global Pharma Healthcare Pvt Ltd has a potential bacterial contamination and the company has violated current good manufacturing practices.

Global Pharma Healthcare, based in the southern city of Chennai, said on Wednesday it had issued a voluntary recall at the consumer level of unexpired lots of the eye drop, which was distributed in the United States by EzriCare LLC and Delsam Pharma.

Global Pharma Healthcare did not immediately respond to a Reuters request seeking comment on the FDA statement.

EzriCare said in a statement on Wednesday that it had stopped further distribution and sale of the eye drop, and it was not aware of any testing that "definitively links" the bacterial outbreak to the product.

The company has removed the products as requested, a Delsam Pharma spokesperson said, adding that the products had a safety seal top and were not associated with customer cases.

An Indian government source told Reuters on Friday that the federal and state drug regulators have sent a team to a manufacturing plant near Chennai contracted by Global Pharma Healthcare.

"It is a contract manufacturing plant supplying through others to the U.S. market," the source said, adding that this specific drug was not sold in India.

The incident comes after the deaths of at least 70 children in Gambia and 19 children in Uzbekistan last year were linked to India-made cough syrups, which has dented the country's image as the "pharmacy of the world".

The FDA said it was collaborating with the Centers for Disease Control and Prevention (CDC) and state and local health departments to investigate a multistate outbreak involving a rare, extensively drug-resistant bacteria.

It said that as of Jan. 31, the CDC had identified 55 patients in 12 states with infections linked to the use of Artificial Tears distributed by EzriCare, it said.

"Associated adverse events include hospitalization, one death with bloodstream infection, and permanent vision loss from eye infections," the FDA said.

Reuters

More

Read more

;

Photos

VIDEOS

‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Latest news